Abstract
BackgroundThe anti-JC virus (JCV) antibody status has been introduced to stratify patients with multiple sclerosis (MS) for higher or lower risk of progressive multifocal leukoencephalopathy (PML).ObjectiveTo assess the potential utility...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have